Skip to main content
Back
Watch Compare

ORTHOPEDIATRICS CORP

Data quality: 100%
KIDS
Nasdaq Manufacturing Measuring & Analyzing Instruments
$15.97
▼ $0.04 (-0.25%)
Mkt Cap: 403.70 M
Price
$15.97
Mkt Cap
403.70 M
Day Range
$15.70 — $16.09
52-Week Range
$14.91 — $23.70
Volume
65,575
Open $15.83
50D / 200D Avg
$17.09
6.53% below
50D / 200D Avg
$18.61
14.17% below

Quick Summary

Key Takeaways

Revenue grew 24.60% annually over 5 years — strong growth
Debt/Equity of 0.30 — conservative balance sheet
Negative free cash flow of -15.96 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.15%
Capital efficient — spends only 4.70% of revenue on capex

Growth

Revenue Growth (5Y)
24.60%
Above sector avg (9.35%)
Revenue (1Y)15.45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-11.25%
Above sector avg (-51.02%)
ROIC-6.70%
Net Margin-16.78%
Op. Margin-16.60%

Safety

Debt / Equity
0.30
Below sector avg (0.33)
Current Ratio7.40
Interest Coverage-1453.26

Valuation

PE (TTM)
-10.18
Below sector avg (-1.98)
P/B Ratio1.16
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -10.2 -2.0
P/B 1.2 5.1
ROE % -11.3 -51.0
Net Margin % -16.8 -150.2
Rev Growth 5Y % 24.6 9.3
D/E 0.3 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.04% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.03% weight
EES logo EES WisdomTree U.S. SmallCap Fund
0.02% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 15.45% Revenue Growth (3Y) 26.06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 24.60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 236.35 M Net Income (TTM) -39.65 M
ROE -11.25% ROA -7.95%
Gross Margin 73.05% Operating Margin -16.60%
Net Margin -16.78% Free Cash Flow (TTM) -15.96 M
ROIC -6.70% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.30 Current Ratio 7.40
Interest Coverage -1453.26 Asset Turnover 0.47
Working Capital 212.62 M Tangible Book Value 182.43 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -10.18 Forward P/E N/A
P/B Ratio 1.16 P/S Ratio 1.71
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3.95%
Market Cap 403.70 M Enterprise Value 492.19 M
Per Share
EPS (Diluted TTM) -1.69 Revenue / Share 9.35
FCF / Share -0.63 OCF / Share -0.19
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4.70% FCF Conversion 40.26%
SBC-Adj. FCF -33.25 M Growth Momentum -9.15

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 236.35 M 204.73 M 148.73 M 122.29 M 98.05 M
Net Income -39.65 M -37.82 M -20.97 M 1.26 M -16.26 M
EPS (Diluted) -1.69 -1.64 -0.92 0.06 -0.84
Gross Profit 172.66 M 148.60 M 111.25 M 90.66 M 73.40 M
Operating Income -39.24 M -35.01 M -26.75 M -25.40 M -18.02 M
EBITDA — — — — —
R&D Expenses 9.10 M 11.03 M 10.20 M 8.01 M 5.54 M
SG&A Expenses — — — — —
D&A 21.12 M 19.08 M 17.39 M 13.10 M 10.68 M
Interest Expense 27,000.0 35,000.0 42,000.0 -2.42 M -2.25 M
Income Tax 460,000.0 -4.11 M -338,000.0 -4.95 M -1.13 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 508.63 M 473.21 M 438.75 M 427.73 M 304.27 M
Total Liabilities 162.03 M 118.64 M 61.72 M 49.08 M 78.91 M
Shareholders' Equity 346.60 M 354.57 M 377.03 M 378.65 M 225.37 M
Total Debt 106.01 M 77.48 M 11.06 M 907,000.0 1.04 M
Cash & Equivalents 19.56 M 43.82 M 31.06 M — 7.64 M
Current Assets 256.42 M 237.17 M 226.50 M 226.72 M 133.65 M
Current Liabilities 46.20 M 33.96 M 41.67 M 30.87 M 29.72 M